• Adriana D Oprea, Maureen C Keshock, Avital Y O'Glasser, Kenneth C Cummings, Angela F Edwards, Andrea Leep Hunderfund, Richard D Urman, and Karen F Mauck.
• Department of Anesthesiology, Yale School of Medicine, New Haven, CT. Electronic address: adriana.oprea@yale.edu.
• Mayo Clin. Proc. 2022 Feb 1; 97 (2): 375-396.

AbstractNeurologic diseases are prevalent in patients undergoing invasive procedures; yet, no societal guidelines exist as to best practice in management of perioperative medications prescribed to treat these disorders. The Society for Perioperative Assessment and Quality Improvement tasked experts in internal medicine, anesthesiology, perioperative medicine, and neurology to provide evidence-based recommendations for preoperative management of these medications. The aim of this review is not only to provide consensus recommendations for preoperative management of patients on medications for neurologic disorders, but also to serve as an educational guide to perioperative clinicians. While, in general, medications for neurologic disorders should be continued preoperatively, an individualized approach may be needed in certain situations (eg, holding anticonvulsants on day of surgery if electroencephalographic mapping is planned during epilepsy surgery). Pertinent interactions with commonly used drugs in anesthesia practice, as well as considerations for targeted laboratory testing or perioperative drug substitutions, are addressed as well.Copyright © 2021 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

36 keywords...

hide…